Subsequent in vitro and in vivo loss‐of‐function experiments confirmed the tumor‐suppressing profile of MSH2 downregulation in glioma, which blocks cell proliferation, disturbs cell migration while inducing cell apoptosis and cell cycle arrest. This evidence concerns the gene MSH2 and central nervous system cancer.